34 related articles for article (PubMed ID: 38470527)
1. Retinal non-perfusion: recognizing and defining what is important.
Cao JA; Al-Khersan H; Chaudhary V; Wykoff CC
Eye (Lond); 2024 Jun; 38(9):1608-1609. PubMed ID: 38438795
[No Abstract] [Full Text] [Related]
2. Response to a letter to editor-comment on: Li D et al. Microstructural and hemodynamic changes in the fundus after pars plana vitrectomy for different vitreoretinal diseases.
Li D; Fu J
Graefes Arch Clin Exp Ophthalmol; 2024 Jun; 262(6):1951-1952. PubMed ID: 38466397
[No Abstract] [Full Text] [Related]
3. Surgical timing and presence of a vitreoretinal fellow on postoperative adverse events following pars plana vitrectomy.
Shields RA; Ludwig CA; Powers MA; Tijerina JD; Schachar IH; Moshfeghi DM
Eur J Ophthalmol; 2020 Jan; 30(1):81-87. PubMed ID: 30426767
[TBL] [Abstract][Full Text] [Related]
4. MACULAR HOLE FORMATION AFTER PARS PLANA VITRECTOMY FOR PRIMARY VITREORETINAL LYMPHOMA.
Haruta M; Taguchi C; Yamakawa R
Retin Cases Brief Rep; 2020; 14(3):243-246. PubMed ID: 29176526
[TBL] [Abstract][Full Text] [Related]
5. [Extracapsular cataract extraction and implantation in the capsular sac during vitrectomy in diabetics].
Pagot V; Gazagne C; Galiana A; Giraud MA; Malecaze F; Mathis A
J Fr Ophtalmol; 1991; 14(10):523-8. PubMed ID: 1791275
[TBL] [Abstract][Full Text] [Related]
6. Retinal oxygen metabolism during normoxia and hyperoxia in healthy subjects.
Palkovits S; Lasta M; Told R; Schmidl D; Boltz A; Napora KJ; Werkmeister RM; Popa-Cherecheanu A; Garhöfer G; Schmetterer L
Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):4707-13. PubMed ID: 25015353
[TBL] [Abstract][Full Text] [Related]
7. Preserve the (intraocular) environment: the importance of maintaining normal oxygen gradients in the eye.
Beebe DC; Shui YB; Siegfried CJ; Holekamp NM; Bai F
Jpn J Ophthalmol; 2014 May; 58(3):225-31. PubMed ID: 24687817
[TBL] [Abstract][Full Text] [Related]
8. Comment on: Li et al. Microstructural and hemodynamic changes in the fundus after pars plana vitrectomy for different vitreoretinal diseases.
Iuliano L; Codenotti F; Bandello F; Codenotti M
Graefes Arch Clin Exp Ophthalmol; 2024 Jun; 262(6):1949-1950. PubMed ID: 38470527
[No Abstract] [Full Text] [Related]
9. Microstructural and hemodynamic changes in the fundus after pars plana vitrectomy for different vitreoretinal diseases.
Li D; Chen H; Huang S; Jia B; Lu L; Fu J
Graefes Arch Clin Exp Ophthalmol; 2023 Nov; ():. PubMed ID: 37982887
[TBL] [Abstract][Full Text] [Related]
10. Combined pars plana vitrectomy and lens management in complex vitreoretinal disease.
Chaudhry NA; Cohen KA; Flynn HW; Murray TG
Semin Ophthalmol; 2003 Sep; 18(3):132-41. PubMed ID: 15513474
[TBL] [Abstract][Full Text] [Related]
11. Pars plana vitrectomy combined with penetrating keratoplasty.
Ikeda T
Semin Ophthalmol; 2001 Sep; 16(3):119-25. PubMed ID: 15513429
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
